ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ConverGene LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10952
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConverGene LLC (ConverGene) is a small molecule discovery company that offers development of cancer drugs targeting the root regulatory mechanisms within cancer cells. The company develops small-molecule drugs that aim at bromodomains, a structural feature of proteins, which mediate epigenetic changes in deoxyribose nucleic acid and packaging proteins. ConverGene’s portfolio includes candidates for the treatment for solid and liquid tumours, and neurological psychiatric disorders. It develops compounds to treat two types of malignancies with orphan disease status, acute myelogenous leukemia and multiple myeloma, among others. The company works in partnership with universities, research institutes and drug development companies. ConverGene is headquartered in Cambridge, Maryland, the US.

ConverGene LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ConverGene Raises USD0.85 Million in Venture Financing 11
Partnerships 12
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
Licensing Agreements 15
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC – Key Competitors 16
ConverGene LLC – Key Employees 17
ConverGene LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
ConverGene LLC, Pharmaceuticals & Healthcare, Key Facts 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene Raises USD0.85 Million in Venture Financing 11
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC, Key Competitors 16
ConverGene LLC, Key Employees 17

List of Figures
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nexus AG (NXU):企業の財務・戦略的SWOT分析
    Summary Nexus AG (Nexus) is a healthcare technology company that provides healthcare software solutions. The company provides products such as NEXUS and HIS, a hospital information system; NEXUS and DIS, a special ward and department solutions; and NEXUS and QM, a solution in quality management, amo …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • City Developments Ltd
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Terumo Cardiovascular Systems Corporation:製品パイプライン分析
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • Steris Plc (STE):製薬・医療:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Julius Baer Group Ltd.:戦略・SWOT・企業財務分析
    Julius Baer Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Julius Baer Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UnionBank of the Philippines (UBP):企業の財務・戦略的SWOT分析
    UnionBank of the Philippines (UBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • Century Insurance Company Limited:企業の戦略・SWOT・財務情報
    Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Banco do Brasil SA:企業のM&A・事業提携・投資動向
    Banco do Brasil SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco do Brasil SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Paychex, Inc. (PAYX):企業の財務・戦略的SWOT分析
    Paychex, Inc. (PAYX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Petroleum & Chemical Corporation (600028)-石油・ガス分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Corning Inc (GLW):医療機器:M&Aディール及び事業提携情報
    Summary Corning Inc (Corning) manufactures and sells ceramics, specialty glasses, and related materials. The company offers glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceram …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆